Suppr超能文献

肿瘤抑制性微小RNA-136-5p调节肾细胞癌的细胞功能。

Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.

作者信息

Chen Peijie, Zhao Liwen, Pan Xiang, Jin Lu, Lin Canbin, Xu Weijie, Xu Jinling, Guan Xin, Wu Xueling, Wang Yong, Yang Shangqi, Wang Tao, Lai Yongqing

机构信息

Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.

Department of Urology, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.

出版信息

Oncol Lett. 2018 Apr;15(4):5995-6002. doi: 10.3892/ol.2018.8081. Epub 2018 Feb 16.

Abstract

MicroRNAs (miRs) are involved in diverse physiological and developmental processes at the post-transcriptional level in cells. Previous studies have demonstrated that miR-136-5p is involved in certain types of cancer. However, the function of miR-136-5p in renal cell carcinoma (RCC) remains to be fully elucidated. In present study, miR-136-5p expression levels were determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and MTT assays, CCK-8 assays, Transwell assays, wound healing assays and flow cytometry were performed to investigate the function of miR-136-5p in RCC. RT-qPCR revealed that the expression of miR-136 was significantly lower in RCC tissues and cells compared with adjacent non-tumor tissues and cells . miR-136-5pwas also demonstrated to be associated with RCC cell proliferation, viability, migration, invasion and apoptosis. miR-136-5p may therefore function as a tumor suppressor in RCC. Further studies are required to elucidate the molecular mechanisms and signaling pathways underlying these functions of miR-136-5p, to investigate the potential function of miR-136-5p as a biomarker for the early detection and prognosis of RCC, and its potential as a therapeutic target for the treatment of RCC.

摘要

微小RNA(miRs)在细胞转录后水平参与多种生理和发育过程。先前的研究表明,miR-136-5p参与某些类型的癌症。然而,miR-136-5p在肾细胞癌(RCC)中的功能仍有待充分阐明。在本研究中,通过逆转录-定量聚合酶链反应(RT-qPCR)测定miR-136-5p表达水平,并进行MTT法、CCK-8法、Transwell法、伤口愈合试验和流式细胞术以研究miR-136-5p在RCC中的功能。RT-qPCR显示,与相邻非肿瘤组织和细胞相比,RCC组织和细胞中miR-136的表达显著降低。miR-136-5p还被证明与RCC细胞增殖、活力、迁移、侵袭和凋亡有关。因此,miR-136-5p可能在RCC中发挥肿瘤抑制作用。需要进一步研究以阐明miR-136-5p这些功能背后的分子机制和信号通路,研究miR-136-5p作为RCC早期检测和预后生物标志物的潜在功能,以及其作为RCC治疗靶点的潜力。

相似文献

1
Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.
Oncol Lett. 2018 Apr;15(4):5995-6002. doi: 10.3892/ol.2018.8081. Epub 2018 Feb 16.
2
MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma.
Exp Ther Med. 2018 Feb;15(2):1686-1693. doi: 10.3892/etm.2017.5581. Epub 2017 Nov 28.
3
Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Life Sci. 2018 Sep 15;209:481-489. doi: 10.1016/j.lfs.2018.08.044. Epub 2018 Aug 21.
4
MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
Biomed Pharmacother. 2019 Mar;111:517-526. doi: 10.1016/j.biopha.2018.12.102. Epub 2018 Dec 28.
5
Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Exp Ther Med. 2018 Apr;15(4):4019-4028. doi: 10.3892/etm.2018.5908. Epub 2018 Feb 28.
6
Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Mol Med Rep. 2016 Jun;13(6):5386-92. doi: 10.3892/mmr.2016.5205. Epub 2016 Apr 28.
7
miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.
Exp Ther Med. 2018 Jul;16(1):436-444. doi: 10.3892/etm.2018.6151. Epub 2018 May 10.
8
9
miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.
Oncol Lett. 2017 Nov;14(5):5624-5630. doi: 10.3892/ol.2017.6855. Epub 2017 Aug 31.
10
miR-216a-5p acts as an oncogene in renal cell carcinoma.
Exp Ther Med. 2018 Apr;15(4):4039-4046. doi: 10.3892/etm.2018.5881. Epub 2018 Feb 20.

引用本文的文献

2
Extracellular vesicles derived from bone marrow mesenchymal stem cells ameliorate chronic liver damage via microRNA-136-5p.
Mol Cell Biochem. 2025 Feb;480(2):951-969. doi: 10.1007/s11010-024-04993-3. Epub 2024 Apr 23.
3
LncRNA MIR100HG Promotes Cell Proliferation in Nasopharyngeal Carcinoma by Targeting miR-136-5p/IL-6 Axis.
Mol Biotechnol. 2024 May;66(5):1279-1289. doi: 10.1007/s12033-023-01028-y. Epub 2024 Jan 26.
4
Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer.
J Egypt Natl Canc Inst. 2023 Jun 26;35(1):19. doi: 10.1186/s43046-023-00172-5.
5
The tumor suppressor function of hsa_circ_0006282 in gastric cancer through PTEN/AKT pathway.
Int J Clin Oncol. 2022 Oct;27(10):1562-1569. doi: 10.1007/s10147-022-02210-z. Epub 2022 Jul 7.
7
Long non-coding RNA NORAD induces phenotypic regulation of vascular smooth muscle cells through regulating microRNA-136-5p-targeted KDM1A.
Cell Cycle. 2021 Oct;20(20):2137-2148. doi: 10.1080/15384101.2021.1971351. Epub 2021 Sep 29.
8
Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/ axis.
Bioengineered. 2021 Dec;12(1):6748-6758. doi: 10.1080/21655979.2021.1964157.

本文引用的文献

1
MicroRNAs in clear cell renal cell carcinoma: biological functions and applications.
J Kidney Cancer VHL. 2015 Aug 23;2(4):140-152. doi: 10.15586/jkcvhl.2015.40. eCollection 2015.
2
Management of metastatic renal cell carcinoma - mini review.
J Kidney Cancer VHL. 2015 May 5;2(2):75-83. doi: 10.15586/jkcvhl.2015.28. eCollection 2015.
3
Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
J Kidney Cancer VHL. 2014 Dec 24;1(8):84-98. doi: 10.15586/jkcvhl.2014.19. eCollection 2014.
4
Renal cell carcinoma.
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
5
MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2.
Tumour Biol. 2017 Feb;39(2):1010428317691184. doi: 10.1177/1010428317691184.
6
MiR-136 contributes to pre-eclampsia through its effects on apoptosis and angiogenesis of mesenchymal stem cells.
Placenta. 2017 Feb;50:102-109. doi: 10.1016/j.placenta.2017.01.102. Epub 2017 Jan 11.
8
Non-coding RNAs: the cancer genome dark matter that matters!
Clin Chem Lab Med. 2017 May 1;55(5):705-714. doi: 10.1515/cclm-2016-0740.
10
Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Cancer Biomark. 2017;18(1):79-85. doi: 10.3233/CBM-160676.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验